AOPEP and acute lymphoblastic leukemia: To the best of our knowledge, this is the first study aiming to evaluate whether serum Apo distribution is deteriorated by anticancer chemotherapeutics in a weight-dependent manner, as well as showing an in-depth analysis of the correlation between Apo composition, body mass index (BMI), and anticancer treatment used among pediatric ALL survivors.